Alpha 1-antitrypsin deficiency and liver disease

B cell activating factor (BAFF) in the natural history of chronic hepatitis C virus liver disease and mixed cryoglobulinaemia.

Clinical and experimental immunology·2012

Current and future therapy for chronic hepatitis C virus liver disease.

Current drug targets. Infectious disorders·2003

Molecular genotyping of human cryptosporidiosis in Northern Ireland: epidemiological aspects and review.

Irish journal of medical science·2002

PCR-IMS detection and molecular typing of Cryptosporidium parvum recovered from a recreational river source and an associated mussel (Mytilus edulis) bed in Northern Ireland.

Epidemiology and infection·2002

Occurrence and molecular genotyping of Cryptosporidium spp. in surface waters in Northern Ireland.

Journal of applied microbiology·2001

Differential effects of nucleoside analogs on oxidative phosphorylation in human pancreatic cells.

Digestive diseases and sciences·2001

Efficacy and safety of upadacitinib in adults and adolescents for treatment of non-segmental vitiligo (Viti-Up): results of two phase 3 randomised controlled studies.

Lancet (London, England)·2026

Belzutifan plus lenvatinib versus cabozantinib in patients with previously treated advanced renal cell carcinoma (LITESPARK-011): an open-label, randomised, controlled, phase 3 trial.

Lancet (London, England)·2026

Switch to once-weekly, single-tablet islatravir-lenacapavir from daily standard of care for HIV-1 (ISLEND-2): a multicentre, randomised, open-label, active-controlled, phase 3 non-inferiority trial.

Lancet (London, England)·2026

[177Lu]Lu-PSMA-617 in patients with PSMA-positive metastatic androgen pathway modulator-naive/sensitive prostate cancer (PSMAddition): a phase 3 randomised, controlled trial.

Lancet (London, England)·2026

Nanoparticle-enabled CD40 silencing programs immune tolerance via a DC-Treg-Breg axis in autoimmune myocarditis.

Materials today. Bio·2026

Infliximab-Associated IgA Vasculitis Masquerading as Crohn's Disease Relapse: Leukocytoclastic Vasculitis Confirmed on Duodenal Biopsy - A Case Report.

Inflammatory intestinal diseases·2026

Ethosuximide-induced lupus erythematosus: Unveiling a rare adverse reaction through systematic review.

Epilepsy & behavior reports·2026

Case Report: Elderly anti-GBM antibody disease with diffuse non-hereditary glomerular basement membrane thinning of uncertain etiology.

Frontiers in medicine·2026

Autoimmune thyroiditis in pregnancy: epidemiology, clinical impact, and contemporary management challenges.

Journal of medicine and life·2026

TREM2 as a central immunometabolic hub in Alzheimer's disease: linking microglial states, lipid stress, and disease-stage-specific intervention.

Frontiers in immunology·2026

Related Experiment Videos

Alpha 1-antitrypsin deficiency and liver disease

Related Concept Videos

B cell activating factor (BAFF) in the natural history of chronic hepatitis C virus liver disease and mixed cryoglobulinaemia.

Current and future therapy for chronic hepatitis C virus liver disease.

Molecular genotyping of human cryptosporidiosis in Northern Ireland: epidemiological aspects and review.

PCR-IMS detection and molecular typing of Cryptosporidium parvum recovered from a recreational river source and an associated mussel (Mytilus edulis) bed in Northern Ireland.

Occurrence and molecular genotyping of Cryptosporidium spp. in surface waters in Northern Ireland.

Differential effects of nucleoside analogs on oxidative phosphorylation in human pancreatic cells.

Efficacy and safety of upadacitinib in adults and adolescents for treatment of non-segmental vitiligo (Viti-Up): results of two phase 3 randomised controlled studies.

Belzutifan plus lenvatinib versus cabozantinib in patients with previously treated advanced renal cell carcinoma (LITESPARK-011): an open-label, randomised, controlled, phase 3 trial.

Switch to once-weekly, single-tablet islatravir-lenacapavir from daily standard of care for HIV-1 (ISLEND-2): a multicentre, randomised, open-label, active-controlled, phase 3 non-inferiority trial.

[177Lu]Lu-PSMA-617 in patients with PSMA-positive metastatic androgen pathway modulator-naive/sensitive prostate cancer (PSMAddition): a phase 3 randomised, controlled trial.

Nanoparticle-enabled CD40 silencing programs immune tolerance via a DC-Treg-Breg axis in autoimmune myocarditis.

Infliximab-Associated IgA Vasculitis Masquerading as Crohn's Disease Relapse: Leukocytoclastic Vasculitis Confirmed on Duodenal Biopsy - A Case Report.

Ethosuximide-induced lupus erythematosus: Unveiling a rare adverse reaction through systematic review.

Case Report: Elderly anti-GBM antibody disease with diffuse non-hereditary glomerular basement membrane thinning of uncertain etiology.

Autoimmune thyroiditis in pregnancy: epidemiology, clinical impact, and contemporary management challenges.

TREM2 as a central immunometabolic hub in Alzheimer's disease: linking microglial states, lipid stress, and disease-stage-specific intervention.

Related Experiment Videos

Alpha 1-antitrypsin deficiency and liver disease

Related Concept Videos

Related Articles